Mayo Clinic researchers found that the component, called epigallocatechin-3-gallate (EGCG), destroys leukaemia cells by interrupting the communication signals they need to survive. The research appears online in the journal Blood.

Advertisement

CLL is most often diagnosed in people in their mid-to-late 60s. Chemotherapy is used to treat the most severe cases, but there is no cure for CLL.

In this study, the Mayo scientists found that EGCG prompted leukaemia cells to die in eight of 10 patient samples tested in a laboratory.

We're continuing to look for therapeutic agents that are non-toxic to the patient but kill cancer cells, and this finding with EGCG is an excellent start, study leader Dr Neil Kay said in a prepared statement. Understanding this mechanism and getting these positive early results gives us a lot to work with in terms of offering patients with this disease more effective, easily tolerated therapies earlier. - (HealthDayNews)

Read more:
Herb weakens leukaemia drug
Toxin combo may treat leukaemia

 

Print this article on

Rate this article Poor 1 2 3 4 5 Excellent

JOBS

Senior Secretary Gauteng - North/Sandton Infrastructure Resource Gauteng - Johannesburg Management Accountant R450,000-500,000 Per Annum Cost To Company Gauteng - Johannesburg Financial Manager R350,000-400,000 Per Annum Cost To Company Gauteng - Johannesburg Financial and Project Accountant R300,000-360,000 Per Annum Cost To Company Gauteng - Johannesburg Financial Accountant R380,000-420,000 Per Annum Cost To Company Gauteng - Johannesburg SSIS Business Intelligence Specialists (SSIS; SSAS) R350,000-500,000 Per Annum Cost To Company Gauteng - North/Sandton Financial Accountant R350,000-450,000 Per Annum Cost To Company Gauteng - South Find more jobs Register your CV Post a job